193 related articles for article (PubMed ID: 9366317)
1. The role of oxybutynin in spinal cord injured patients with indwelling catheters.
Kim YH; Bird ET; Priebe M; Boone TB
J Urol; 1997 Dec; 158(6):2083-6. PubMed ID: 9366317
[TBL] [Abstract][Full Text] [Related]
2. Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detrusor-sphincter dyssynergia.
Kim YH; Kattan MW; Boone TB
J Urol; 1998 Feb; 159(2):493-6; discussion 496-7. PubMed ID: 9649270
[TBL] [Abstract][Full Text] [Related]
3. Intravesical oxybutynin for spinal cord injury patients.
Szollar SM; Lee SM
Spinal Cord; 1996 May; 34(5):284-7. PubMed ID: 8963976
[TBL] [Abstract][Full Text] [Related]
4. Management of spinal cord injured patients by indwelling suprapubic catheterization.
MacDiarmid SA; Arnold EP; Palmer NB; Anthony A
J Urol; 1995 Aug; 154(2 Pt 1):492-4. PubMed ID: 7609115
[TBL] [Abstract][Full Text] [Related]
5. Effect of intermittent urethral catheterization and oxybutynin bladder instillation on urinary continence status and quality of life in a selected group of spinal cord injury patients with neuropathic bladder dysfunction.
Vaidyananthan S; Soni BM; Brown E; Sett P; Krishnan KR; Bingley J; Markey S
Spinal Cord; 1998 Jun; 36(6):409-14. PubMed ID: 9648197
[TBL] [Abstract][Full Text] [Related]
6. Fate of upper urinary tracts in patients with indwelling catheters after spinal cord injury.
Chao R; Clowers D; Mayo ME
Urology; 1993 Sep; 42(3):259-62. PubMed ID: 8379025
[TBL] [Abstract][Full Text] [Related]
7. The safety cutoff storage pressure for preventing upper urinary tract damage in neurogenic bladder from spinal cord pathology and risk factor analysis.
Swatesutipun V; Tangpaitoon T
Neurourol Urodyn; 2022 Apr; 41(4):991-1001. PubMed ID: 35320589
[TBL] [Abstract][Full Text] [Related]
8. Urethral versus suprapubic catheter: choosing the best bladder management for male spinal cord injury patients with indwelling catheters.
Katsumi HK; Kalisvaart JF; Ronningen LD; Hovey RM
Spinal Cord; 2010 Apr; 48(4):325-9. PubMed ID: 19823191
[TBL] [Abstract][Full Text] [Related]
9. Bladder management and risk of bladder stone formation in spinal cord injured patients.
Ord J; Lunn D; Reynard J
J Urol; 2003 Nov; 170(5):1734-7. PubMed ID: 14532765
[TBL] [Abstract][Full Text] [Related]
10. Neurogenic bladder in patients with traumatic spinal cord injury: treatment and follow-up.
; Yıldız N; Akkoç Y; Erhan B; Gündüz B; Yılmaz B; Alaca R; Gök H; Köklü K; Ersöz M; Cınar E; Karapolat H; Catalbaş N; Bardak AN; Turna I; Demir Y; Güneş S; Alemdaroğlu E; Tunç H
Spinal Cord; 2014 Jun; 52(6):462-7. PubMed ID: 24732167
[TBL] [Abstract][Full Text] [Related]
11. Non-surgical urologic management of neurogenic bladder after spinal cord injury.
Romo PGB; Smith CP; Cox A; Averbeck MA; Dowling C; Beckford C; Manohar P; Duran S; Cameron AP
World J Urol; 2018 Oct; 36(10):1555-1568. PubMed ID: 30051263
[TBL] [Abstract][Full Text] [Related]
12. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury.
Pannek J; Sommerfeld HJ; Bötel U; Senge T
Urology; 2000 Mar; 55(3):358-62. PubMed ID: 10699610
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in bladder management in veterans with spinal cord injury and disorders.
Morin JP; King AB; Goetz LL; Wolfe LG; Klausner AP
Neurourol Urodyn; 2019 Mar; 38(3):968-974. PubMed ID: 30801793
[TBL] [Abstract][Full Text] [Related]
14. Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients.
Weld KJ; Graney MJ; Dmochowski RR
J Urol; 2000 Apr; 163(4):1228-33. PubMed ID: 10737503
[TBL] [Abstract][Full Text] [Related]
15. The Role of Health Insurance in Patient Reported Satisfaction with Bladder Management in Neurogenic Lower Urinary Tract Dysfunction Due to Spinal Cord Injury.
Rude T; Moghalu O; Stoffel J; Lenherr S; Myers JB; Elliott S; Welk B; Herrick JS; Presson AP; Ginsberg DA
J Urol; 2021 Jan; 205(1):213-218. PubMed ID: 32856985
[TBL] [Abstract][Full Text] [Related]
16. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
[TBL] [Abstract][Full Text] [Related]
17. Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients.
Feifer A; Corcos J
Neurourol Urodyn; 2008; 27(6):475-9. PubMed ID: 18551568
[TBL] [Abstract][Full Text] [Related]
18. Intradetrusor onabotulinumtoxinA injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, controlled, 24-week trial.
Ferreira RS; D'Ancona CAL; Oelke M; Carneiro MR
Einstein (Sao Paulo); 2018 Aug; 16(3):eAO4207. PubMed ID: 30088545
[TBL] [Abstract][Full Text] [Related]
19. Bladder management in individuals with chronic neurogenic lower urinary tract dysfunction.
Krebs J; Wöllner J; Pannek J
Spinal Cord; 2016 Aug; 54(8):609-13. PubMed ID: 26554274
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury.
George J; Tharion G; Richar J; Macaden AS; Thomas R; Bhattacharji S
ScientificWorldJournal; 2007 Oct; 7():1683-90. PubMed ID: 17982563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
